Boston Sci Buys Asthma Treatment Maker For $443M

Law360, New York (September 20, 2010, 2:33 PM EDT) -- Medical device maker Boston Scientific Corp. said Monday that it would pay up to $443.5 million to acquire privately held Asthmatx Inc., which produces and markets a recently approved nondrug treatment for severe asthma.

The deal calls for Boston Scientific to make an up-front payment of $193.5 million and additional payments of up to $250 million through 2019 if certain revenue-based goals are met. The deal is expected to close in the fourth quarter, subject to customary conditions, Boston Scientific said.

Sunnyvale, Calif.-based Asthmatx markets the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.